Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) gapped down prior to trading on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $9.92, but opened at $9.3364. Nihon Kohden shares last traded at $9.3364, with a volume of 192 shares trading hands.
The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.06). Nihon Kohden had a return on equity of 9.17% and a net margin of 5.90%.
Analyst Upgrades and Downgrades
Separately, UBS Group lowered Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 12th. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Nihon Kohden currently has an average rating of “Hold”.
Get Our Latest Research Report on Nihon Kohden
Nihon Kohden Stock Down 5.9%
The firm has a 50 day simple moving average of $10.06 and a 200-day simple moving average of $9.78. The company has a quick ratio of 2.64, a current ratio of 3.98 and a debt-to-equity ratio of 0.12. The stock has a market cap of $1.57 billion, a P/E ratio of 16.98 and a beta of 0.42.
Nihon Kohden Company Profile
Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and sells electronic medical equipment and related services. Founded in 1951, the company is headquartered in Tokyo, Japan.
Its products include patient monitors, electrocardiographs, defibrillators and other equipment used in emergency and critical care. Nihon Kohden also makes diagnostic systems for areas such as neurology and hematology, along with medical information systems and services that support clinical workflows.
The company serves healthcare providers in Japan and international markets through its overseas subsidiaries and distribution network.
See Also
- Five stocks we like better than Nihon Kohden
- Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
